miR-17 promotes expansion and adhesion of human cord blood CD34(+) cells in vitro

Stem Cell Research & Therapy
Yuxia YangJianyuan Luo

Abstract

We have recently found that miR-17 is necessary in the cell-extrinsic control of cord blood (CB) CD34(+) cell function. Here, we demonstrated that the proper level of miR-17 is also necessary in the cell-intrinsic control of the hematopoietic properties of CB CD34(+) cells. The miR-17 overexpression and knockdown models were created using primary CB CD34(+) cells transfected by the indicated vectors. Long-term culture, colony forming, adhesion and trans-well migration assays were carried out to investigate the function of miR-17 on CB CD34(+) cells in vitro. NOD prkdc (scid) Il2rg (null) mice were used in a SCID repopulating cell assay to investigate the function of miR-17 on CB CD34(+) cells in vivo. A two-tailed Student's t-test was used for statistical comparisons. In vitro assays revealed that ectopic expression of miR-17 promoted long-term expansion, especially in the colony-forming of CB CD34(+) cells and CD34(+)CD38(-) cells. Conversely, downregulation of miR-17 inhibited the expansion of CB CD34(+) cells. However, the overexpression of miR-17 in vivo reduced the hematopoietic reconstitution potential of CB CD34(+) cells compared to that of control cells. The increased expression of major adhesion molecules in miR-17 ove...Continue Reading

References

Aug 1, 1992·The Journal of Clinical Investigation·J TeixidóP Anklesaria
Feb 26, 2000·Science·F M Watt, B L Hogan
Dec 6, 2003·Science·Chang-Zheng ChenDavid P Bartel
Mar 22, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ramiro GarzonCarlo M Croce
Mar 22, 2006·Nature Immunology·Gregor B Adams, David T Scadden
Feb 13, 2007·Proceedings of the National Academy of Sciences of the United States of America·Robert W GeorgantasCurt I Civin
Mar 9, 2007·Genes & Development·Joel R NeilsonPhillip A Sharp
Oct 16, 2007·Oncogene·H Iwasaki, K Akashi
Feb 26, 2008·Cell·Stuart H Orkin, Leonard I Zon
Oct 8, 2008·Current Opinion in Genetics & Development·Diego Miranda-Saavedra, Berthold Göttgens
Feb 26, 2009·Cell·Richard W Carthew, Erik J Sontheimer
May 14, 2009·Stem Cells and Development·Michaela MerkerovaHana Bruchova
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ryan M O'ConnellDavid Baltimore
Dec 2, 2010·Proceedings of the National Academy of Sciences of the United States of America·A G Lisa OoiChristopher Y Park
Nov 13, 2012·Cell Stem Cell·Eric R LechmanLuigi Naldini

❮ Previous
Next ❯

Citations

Mar 7, 2021·Pathogens·Nicole L DigginsMeaghan H Hancock

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
transfection
PCR
fluorescence microscopy
flow

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Biophysics of Adhesion

Alterations in cell adhesion can disrupt important cellular processes and lead to a variety of diseases, including cancer and arthritis. It is also essential for infectious organisms, such as bacteria or viruses, to cause diseases. Understanding the biophysics of cell adhesion can help understand these diseases. Discover the latest research on the biophysics of adhesion here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.